Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 31/74 ]
NASDAQ | Common Stock
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.
It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room.
LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 3, 25 | -0.10 Increased by +71.97% | -0.18 Increased by +45.50% |
| Nov 7, 24 | -0.13 Increased by +43.48% | -0.29 Increased by +55.17% |
| Aug 8, 24 | -0.79 Increased by +2.47% | -0.29 Decreased by -172.41% |
| May 9, 24 | -0.19 Increased by +52.50% | -0.28 Increased by +32.14% |
| Mar 4, 24 | -0.35 Decreased by -45.83% | -0.22 Decreased by -59.09% |
| Nov 9, 23 | -0.23 Increased by +41.03% | -0.34 Increased by +32.35% |
| Aug 9, 23 | -0.81 Decreased by -20.90% | -0.35 Decreased by -131.43% |
| May 15, 23 | -0.40 Increased by +40.30% | -0.27 Decreased by -48.15% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 13.54 M Increased by +38.22% | -1.50 M Decreased by -158.49% | Decreased by -11.09% Decreased by -142.31% |
| Jun 30, 24 | 12.64 M Increased by +5.19% | -9.04 M Decreased by -3.31% | Decreased by -71.57% Increased by +1.79% |
| Mar 31, 24 | 10.59 M Increased by +28.31% | -2.16 M Increased by +51.63% | Decreased by -20.37% Increased by +62.30% |
| Dec 31, 23 | 12.11 M Increased by +18.31% | -3.93 M Decreased by -23.03% | Decreased by -32.43% Decreased by -4.00% |
| Sep 30, 23 | 9.79 M Increased by +26.42% | 2.57 M Increased by +165.86% | Increased by +26.22% Increased by +152.10% |
| Jun 30, 23 | 12.01 M Increased by +49.44% | -8.75 M Decreased by -30.25% | Decreased by -72.87% Increased by +12.84% |
| Mar 31, 23 | 8.25 M Decreased by -11.65% | -4.46 M Increased by +33.10% | Decreased by -54.04% Increased by +24.28% |
| Dec 31, 22 | 10.23 M Decreased by -8.82% | -3.19 M Increased by +18.22% | Decreased by -31.19% Increased by +10.31% |